Authors: Park, S Merlat, A Guesnu, M Picard, F Viguie, F Vassilieff, D Dreyfus, F

Citation: S. Park et al., Pure red cell aplasia associated with myelodysplastic syndromes, LEUKEMIA, 14(9), 2000, pp. 1709-1710

Authors: Bouscary, D Chen, YL Guesnu, M Picard, F Viguier, F Lacombe, C Dreyfus, F Fontenay-Roupie, M

Citation: D. Bouscary et al., Activity of the caspase-3/CPP32 enzyme is increased in "early stage" myelodysplastic syndromes with excessive apoptosis, but caspase inhibition does not enhance colony formation in vitro, EXP HEMATOL, 28(7), 2000, pp. 784-791

Authors: Picard, F Gicquel, C Marnet, L Guesnu, M Levy, JP

Citation: F. Picard et al., Preliminary evaluation of the new hematology analyzer COULTER (R) GEN center dot STM in a university hospital, CLIN CH L M, 37(6), 1999, pp. 681-686

Authors: Fontenay-Roupie, M Bouscary, D Guesnu, M Picard, F Melle, J Lacombe, C Gisselbrecht, S Mayeux, P Dreyfus, F

Citation: M. Fontenay-roupie et al., Ineffective erythropoiesis in myelodysplastic syndromes: correlation with Fas expression but not with lack of erythropoietin receptor signal transduction, BR J HAEM, 106(2), 1999, pp. 464-473

Authors: Fichelson, S Freyssinier, JM Picard, F Fontenay-Roupie, M Guesnu, M Cherai, M Gisselbrecht, S Porteu, F

Citation: S. Fichelson et al., Megakaryocyte growth and development factor-induced proliferation and differentiation are regulated by the mitogen-activated protein kinase pathway in primitive cord blood hematopoietic progenitors, BLOOD, 94(5), 1999, pp. 1601-1613